http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
With U.S.-Cuba detente, a battle over trademarks looms
-
Merck KGaA, Darmstadt, Germany, and Pfizer Receive Positive Opinion for Orphan Drug Designation for Avelumab in Merkel Cell Carcinoma from EMA Committee for Orphan Medicinal Products
-
Pfizer Receives European Approval to Expand Use of XALKORI® (crizotinib) to First-Line Treatment of Adults with ALK-Positive Advanced Non-Small Cell Lung Cancer
-
Bristol-Myers Squibb and Pfizer to Present New Data on Eliquis (apixaban) at the American Heart Association (AHA) Scientific Sessions 2015
-
Wall St. slips on rate uncertainty; Apple up after the bell
-
Trading Radar for 10/26: Apple (AAPL), Twitter (TWTR), Alibaba (BABA), Comcast (CMCSA), Pfizer (PFE) Report
-
Pre-Open Stock Movers 10/13: (WPP) (PLX) (TWTR) Higher; (EOX) (HTWR) (FMC) Lower (more...)
-
Pfizer Partners with Breast Cancer Leaders to Chronicle the Lives of Women with Metastatic Breast Cancer through the Lenses of Prominent Photographers
-
FTC Offers Additional Detail of Conditions for Pfizer (PFE) to Complete Hospira (HSP) Acquisition
-
Bristol-Myers Squibb and Pfizer to Present New Data on Eliquis (apixaban) at the ESC Congress 2015
-
Market Wrap: Markets Rebound on Easing China Fears; Consumer Confidence Slips in July; Twitter Outperforms in Q2
-
Wall Street bounces back after five-day selloff
-
Trading Radar for 7/28: Ford (F), Twitter (TWTR) DuPont (DD), Pfizer (PFE), UPS (UPS), US Steel (X) Report
-
New Online Community, Quitter’s Circle, Helps Smokers Trade Cigarettes for Real-Time Support
-
Portola, Bristol-Myers Squibb and Pfizer Announce Full Results of Second Part of Phase 3 ANNEXA-A(TM) Study Demonstrating That Investigational Andexanet Alfa Sustained Reversal of Anticoagulant Effect
-
Portola, Bristol-Myers Squibb and Pfizer Announce Full Results of Second Part of Phase 3 ANNEXA-A(TM) Study Demonstrating That Investigational Andexanet Alfa Sustained Reversal of Anticoagulant Effect
-
Trading Radar for 4/28: Ford (F), Aetna (AET), Twitter (TWTR), GoPro (GPRO), Panera Bread (PNRA) Report
-
Top 10 News for 2/2 - 2/6: Payroll Gains Outpace in Jan.; Obama Proposes FY16 Budget; More Office Goods Retailer Consolidation
-
Market Wrap: Pfizer Inks Big Deal; GoPro Hit on Outlook; RadioShack Goes Belly-Up
-
Pre-Open Stock Movers 02/05: (HSP) (EOPN) (DATA) (TWTR) Higher; (QUIK) (ADEP) (IRBT) Lower (more...)
-
Pre-Open Stock Movers 12/15: (TLM) (OPK) (CRUS) Higher; (UPIP) (XCO) (F) Lower (more...)
-
Market Wrap: Valeant Lifts Allergan Bid; Twitter's Ho-Hum Q3 Report; Tesla Slumps on Sales Speculation
-
Market Wrap: Home Prices Gain at Slower Pace; Twitter Soars in Q2; Ford Opts for Apple
-
Trading Radar for 07/29: Pfizer (PFE), Marriott (MAR), UPS (UPS), Anadarko (APC), Ballard Power (BLDP) Report
-
Top 10 News for 05/27 - 05/30: Hillshire's Bidding War; Apple's Got the 'Beats'; More Love for Twitter
-
Notable Analyst Rating Changes 05/28: (COP) (TWTR) (AUXL) Upgraded; (DG) (LOW) (VOD) Downgraded
-
Semi-Annual Changes to the NASDAQ OMX CRD Global Sustainability Index
-
Top 10 News for 02/03 - 02/07: Scepter Passed at Microsoft; Twitter's Post-IPO High Fades; Jobs Absent in Jan.
-
Highlights From AAPL's Q4 Conference Call: Set New All-Time Records for Mac, iPhone and iPad Sales

